Birdwatch Note
2024-03-08 11:57:06 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
mRNA technology has garnered significant attention in cancer research. mRNA technology holds promise for both infectious diseases & cancer treatment. As research progresses, we may witness breakthroughs that revolutionize how we beat cancer & other illnesses. https://www.scientificamerican.com/article/new-cancer-vaccines-could-treat-some-types-of-pancreatic-colorectal-and-other-deadly-forms-of-the-disease/ https://www.cancer.gov/news-events/cancer-currents-blog/2022/mrna-vaccines-to-treat-cancer https://www.alcimed.com/en/insights/mrna-cancer-therapy/ https://www.aamc.org/news/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases https://cancerblog.mayoclinic.org/2022/01/11/mayo-clinic-research-finds-immune-system-responds-to-mrna-treatment-for-cancer/
Written by 5CB448A5B8D03939ABCA5A0BB4667E78774F5C2DC839ACED0E98DA7D7131EDBA
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1765967320050983302
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1766070636202406023
- noteId - 1766070636202406023
- participantId -
- noteAuthorParticipantId - 5CB448A5B8D03939ABCA5A0BB4667E78774F5C2DC839ACED0E98DA7D7131EDBA
- createdAtMillis - 1709899026334
- tweetId - 1765967320050983302
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- mRNA technology has garnered significant attention in cancer research. mRNA technology holds promise for both infectious diseases & cancer treatment. As research progresses, we may witness breakthroughs that revolutionize how we beat cancer & other illnesses. https://www.scientificamerican.com/article/new-cancer-vaccines-could-treat-some-types-of-pancreatic-colorectal-and-other-deadly-forms-of-the-disease/ https://www.cancer.gov/news-events/cancer-currents-blog/2022/mrna-vaccines-to-treat-cancer https://www.alcimed.com/en/insights/mrna-cancer-therapy/ https://www.aamc.org/news/mrna-technology-promises-revolutionize-future-vaccines-and-treatments-cancer-infectious-diseases https://cancerblog.mayoclinic.org/2022/01/11/mayo-clinic-research-finds-immune-system-responds-to-mrna-treatment-for-cancer/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2024-03-08 11:57:06 UTC (1709899026334) |
2024-03-08 18:14:15 UTC (1709921655502) |
CURRENTLY_RATED_HELPFUL | 2024-03-10 02:46:15 UTC (1710038775311) |
CURRENTLY_RATED_HELPFUL | 2024-03-08 18:14:15 UTC (1709921655502) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2024-03-08 14:55:51 -0600 | Rating Details | |
2024-03-08 11:13:17 -0600 | Rating Details | |
2024-03-08 10:05:59 -0600 | Rating Details | |
2024-03-08 09:53:16 -0600 | Rating Details | |
2024-03-08 08:12:23 -0600 | Rating Details | |
2024-03-08 07:34:25 -0600 | Rating Details | |
2024-03-08 07:30:45 -0600 | Rating Details | |
2024-03-08 07:26:18 -0600 | Rating Details | |
2024-03-08 07:11:21 -0600 | Rating Details | |
2024-03-08 06:37:16 -0600 | Rating Details | |
2024-03-08 06:25:21 -0600 | Rating Details | |
2024-03-08 06:21:00 -0600 | Rating Details | |
2024-03-08 06:20:05 -0600 | Rating Details | |
2024-03-08 06:19:39 -0600 | Rating Details | |
2024-03-08 06:15:35 -0600 | Rating Details | |
2024-03-08 06:02:35 -0600 | Rating Details | |
2024-03-08 11:47:01 -0600 | Rating Details | |
2024-03-08 10:47:43 -0600 | Rating Details | |
2024-03-08 10:22:38 -0600 | Rating Details | |
2024-03-08 08:31:39 -0600 | Rating Details | |
2024-03-08 08:16:10 -0600 | Rating Details | |
2024-03-08 08:00:05 -0600 | Rating Details | |
2024-03-08 07:24:31 -0600 | Rating Details | |
2024-03-08 06:44:45 -0600 | Rating Details | |
2024-03-08 06:33:55 -0600 | Rating Details | |
2024-03-08 06:29:44 -0600 | Rating Details | |
2024-03-08 06:21:33 -0600 | Rating Details | |
2024-03-08 06:15:09 -0600 | Rating Details | |
2024-03-08 06:08:13 -0600 | Rating Details | |
2024-03-08 05:59:45 -0600 | Rating Details | |
2024-03-08 05:58:36 -0600 | Rating Details | |
2024-03-09 08:26:27 -0600 | Rating Details | |
2024-03-08 08:06:57 -0600 | Rating Details | |
2024-03-08 07:46:46 -0600 | Rating Details | |
2024-03-08 07:44:20 -0600 | Rating Details | |
2024-03-08 07:25:50 -0600 | Rating Details | |
2024-03-08 07:04:38 -0600 | Rating Details | |
2024-03-08 06:44:40 -0600 | Rating Details | |
2024-03-08 06:34:44 -0600 | Rating Details | |
2024-03-08 06:33:02 -0600 | Rating Details | |
2024-03-08 06:23:34 -0600 | Rating Details | |
2024-03-08 06:22:38 -0600 | Rating Details | |
2024-03-08 06:18:05 -0600 | Rating Details | |
2024-03-08 05:59:31 -0600 | Rating Details | |
2024-03-08 05:57:32 -0600 | Rating Details | |
2024-03-15 01:37:04 -0500 | Rating Details | |
2024-03-15 01:36:41 -0500 | Rating Details | |
2024-03-15 01:31:04 -0500 | Rating Details | |
2024-03-12 10:52:30 -0500 | Rating Details |